| Literature DB >> 34163277 |
Ayse Irem Sonmez1,2, Charles P Lewis1, Arjun P Athreya3, Julia Shekunov2, Paul E Croarkin2.
Abstract
INTRODUCTION: Major depressive disorder (MDD) is a common condition with heterogeneous presentations that often include predominant anhedonia. Previous studies have revealed that childhood trauma is a potent risk factor for the development of MDD; however, the clinical implications of this finding are not fully understood.Entities:
Keywords: adolescent; anhedonia; emotional abuse
Year: 2021 PMID: 34163277 PMCID: PMC8213949 DOI: 10.2147/AHMT.S300150
Source DB: PubMed Journal: Adolesc Health Med Ther ISSN: 1179-318X
Childhood Trauma Questionnaire Cutoff Scores
| Level of Abuse | Emotional Abuse | Physical Abuse | Sexual Abuse | Emotional Neglect | Physical Neglect |
|---|---|---|---|---|---|
| None | 8 | 7 | 5 | 9 | 7 |
| Low | 12 | 9 | 7 | 14 | 9 |
| Moderate | 15 | 12 | 12 | 17 | 12 |
| Severe | 16+ | 13+ | 13+ | 18+ | 13+ |
Notes: CTQ (Childhood Trauma Questionnaire) Manual cutoff scores and categories for each subscale. Example: Those who scored 8 or less in emotional abuse reported minimal or no trauma. Those who scored 9 or higher in emotional abuse reported some level of emotional abuse.
Demographics and Clinical Features
| Combined Sample n = 42 | Healthy vs Depressed | No Trauma vs Trauma Exposure | |||||
|---|---|---|---|---|---|---|---|
| Healthy Control n = 17 | Depressed n = 25 | No Trauma n = 18 | Trauma Exposure n = 24 | ||||
| Age (years) | 16.33 (2.01) | 16.65 (2.21) | 16.12 (1.88) | 0.43 | 16.39 (1.94) | 16.29 (2.1) | 0.367 |
| Female, | 25 (59.5) | 12 (70.6) | 13 (52) | 0.23 | 11 (61) | 14 (58.3) | 0.87 |
| CDRS-R scores | |||||||
| Total Score | 36.69 (18.42) | 19.12 (2.89) | 48.64 (14.37) | <0.001 | 24.33 (11.89) | 45.96 (17.06) | <0.001 |
| Anhedonia subscale | 4.79 (3.05) | 2.12 (0.49) | 6.6 (2.69) | <0.001 | 2.78 (1.96) | 6.29 (2.87) | <0.001 |
| QIDS-A17-SR score | 8.43 (6.45) | 2.71 (2.14) | 12.32 (5.38) | <0.001 | 3.72 (2.22) | 11.96 (6.19) | <0.001 |
| CTQ scores | |||||||
| Total Score | 37.1 (11.04) | 28.35 (3.28) | 43.04 (10.49) | <0.001 | 27.67 (3.73) | 44.17 (9.38) | <0.001 |
| Emotional Abuse Scale | 9.05 (4.23) | 6.06 (1.39) | 11.08 (4.31) | <0.001 | 5.83 (0.99) | 11.46 (4.12) | <0.001 |
| Emotional Neglect Scale | 8.57 (3.85) | 6.41 (1.91) | 10.04 (4.17) | 0.001 | 6.06 (1.66) | 10.46 (3.97) | <0.001 |
| Physical Abuse Scale | 6.45 (2.28) | 5.18 (0.53) | 7.32 (2.59) | 0.001 | 5.28 (0.67) | 7.33 (2.65) | <0.001 |
| Physical Neglect Scale | 6.52 (2.2) | 5.71 (1.36) | 7.08 (2.5) | 0.037 | 5.33 (0.59) | 7.42 (2.54) | 0.012 |
| Sexual Abuse Scale | 6.43 (3.98) | 5 (0) | 7.4 (4.96) | 0.002 | 5 (0) | 7.5 (5.04) | 0.001 |
Notes: Means with standard deviations or % in parentheses. Trauma level is based on CTQ (Childhood Trauma Questionnaire) Manual. Participants who reported none or minimal trauma in all subscales were grouped as “No Trauma”; all others are grouped as “Trauma Exposure”. Anhedonia subscale is the total of CDRS-R items 2 and 3. Sex differences across groups were assessed with Chi-Square. Age and QIDS-A17-SR compared with two samples t-test. CDRS-R total score, Anhedonia subscale score and all CTQ scores were compared with Mann–Whitney U due to skewed distribution of the variable.
Sample Characteristics
| Participant | Group | Trauma Exposure | Medication(s) and Total Daily Dose | Comorbidities | Sex |
|---|---|---|---|---|---|
| 1 | Dep/Med - | EAS, PAS, ENS | None | Cannabis use | M |
| 2 | Dep/Med + | No Trauma | Fluoxetine, methylphenidate hydrochloride ER | ADHD, stimulants were held on day of Scan | F |
| 3 | HC | No Trauma | None | None | F |
| 4 | HC | No Trauma | None | None | F |
| 5 | HC | EAS | None | None | F |
| 6 | HC | No Trauma | None | None | F |
| 7 | Dep/Med - | EAS, SAS, PNS | None | Panic disorder | M |
| 8 | HC | No Trauma | None | None | F |
| 9 | Dep/Med + | EAS, SAS, ENS | Sertraline, aripiprazole | None | M |
| 10 | Dep/Med + | SAS | Fluoxetine | Alcohol use disorder in remission 8 months, anxiety disorder NOS | F |
| 11 | HC | No Trauma | None | None | M |
| 12 | HC | No Trauma | None | None | F |
| 13 | HC | ENS | None | Subthreshold depressive symptoms | F |
| 14 | Dep/Med - | EAS, ENS | None | None | F |
| 15 | Dep/Med - | EAS, PAS, ENS, PNS | None | Cannabis use disorder | M |
| 16 | Dep/Med + | EAS, SAS | Sertraline | None | F |
| 17 | HC | No Trauma | None | None | M |
| 18 | Dep/Med - | EAS, PAS, SAS | None | None | F |
| 19 | Dep/Med - | EAS, SAS, ENS, PNS | None | Alcohol, cannabis, nicotine | F |
| 20 | Dep/Med - | EAS, ENS, PNS | None | None | F |
| 21 | Dep/Med - | EAS, SAS | None | ADHD, Osgood-Schlatter Disease | F |
| 22 | Dep/Med + | EAS, SAS, ENS | Fluoxetine, dextroamphetamine saccharate | ADHD, GAD, Motor Tic Disorder | M |
| 23 | Dep/Med + | EAS, ENS, PNS | Fluoxetine | Cannabis use disorder | M |
| 24 | Dep/Med - | EAS, ENS | None | Persistent dysthymic disorder | F |
| 25 | Dep/Med - | EAS, PAS, ENS, PNS | Methylphenidate hydrochloride | ADHD | M |
| 26 | Dep/Med + | No Trauma | Fluoxetine | Restless leg syndrome, migraines | F |
| 27 | Dep/Med - | EAS, PAS, ENS, PNS | None | Persistent dysthymic disorder, cannabis use disorder | F |
| 28 | HC | No Trauma | None | None | F |
| 29 | HC | PNS | None | None | F |
| 30 | Dep/Med + | No Trauma | Duloxetine | ADHD, minor depressive disorder | M |
| 31 | Dep/Med - | ENS | Methylphenidate, atomoxetine | ADHD | M |
| 32 | Dep/Med + | No Trauma | Bupropion hydrochloride xl | None | M |
| 33 | HC | PNS | None | Cannabis use disorder | M |
| 34 | HC | No Trauma | None | None | M |
| 35 | Dep/Med - | EAS, PAS, SAS, ENS | None | PTSD | F |
| 36 | HC | No Trauma | None | Mild concussion history | M |
| 37 | Dep/Med + | EAS, PAS, SAS | Fluoxetine | Cannabis use disorder | F |
| 38 | Dep/Med + | No Trauma | Amitriptyline | Learning disability, chronic headaches | M |
| 39 | Dep/Med + | EAS, PAS, SAS, ENS | Fluoxetine | None | M |
| 40 | HC | No Trauma | None | None | F |
| 41 | HC | No Trauma | None | None | F |
| 42 | HC | No Trauma | None | None | F |
Notes: “No Trauma” group consisted of participants who scored in the “None or minimal” category on all subscales. This was defined according to Childhood Trauma Questionnaire Manual. The cut-off scores for each scale are shown in Table 1.
Abbreviations: EAS, Emotional Abuse Scale; PAS, Physical Abuse Scale; SAS, Sexual Abuse Scale; ENS, Emotional Neglect Scale; PNS, Physical Neglect Scale.
Generalized Linear Model Results
| β | SE | 95% CI for β | |||
|---|---|---|---|---|---|
| CTQ Total Score | 2.485 | 0.41 | 1.689–3.281 | <0.001 | |
| Emotional Abuse | 0.93 | 0.16 | 0.619–1.241 | <0.001 | |
| Emotional Neglect | 0.67 | 0.17 | 0.346–0.994 | <0.001 | |
| Physical Abuse | 0.228 | 0.11 | 0.014–0.443 | 0.037 | |
| Physical Neglect | 0.306 | 0.1 | 0.109–0.504 | 0.002 | |
| Sexual Abuse | 0.364 | 0.19 | −0.014–0.743 | 0.059 | |
Notes: CTQ total scores and 5 subscale association with CDRS-R Anhedonia Subscale in combined sample (n=42, df=38, 1). Each β and p-value pair represents a separate generalized linear model. Independent variable: CDRS-R Anhedonia Subscale, dependent variable Childhood Trauma Questionnaire scores.
Association of Sexual Abuse Score with Sex and Anhedonia Score
| 95% CI for β | |||||
|---|---|---|---|---|---|
| Parameter | β | SE | Upper | Lower | |
| CDRS-R Anhedonia Subscale | 0.117 | 0.254 | −0.38 | 0.21 | 0.64 |
| Sex | −1.349 | 2.131 | −5.53 | 2.83 | 0.53 |
| Sex * CDRS-R Anhedonia Subscale | 0.751 | 0.368 | 0.029 | 1.47 | 0.042 |
Notes: Dependent variable was Childhood Trauma Questionnaire Sexual Abuse Scale. Sample size and degrees of freedom were n=42, df=38, 1.
Figure 1CTQ Sexual Abuse Scale by Anhedonia in Males and Females.